Professor Ian Chetter's Outputs (4)

Is disease specific quality of life analysis necessary in intermittent claudication?  (2003)
Presentation / Conference Contribution
Mehta, T., Chetter, I., Venkatasubramaniam, A. K., Mylankal, K., Ray, B., & McCollum, P. Is disease specific quality of life analysis necessary in intermittent claudication? 

This study aimed to assess the validity and responsiveness of three disease-specific QoL instruments in intermittent claudication.

Statins offer a protective role against oxidative and hypoxic stress induced vascular endothelial apoptosis (2003)
Presentation / Conference Contribution
Ray, B., Mylankal, K., McCollum, P., Chetter, I., & Ettelaie, C. Statins offer a protective role against oxidative and hypoxic stress induced vascular endothelial apoptosis

A novel disease-specific quality of life questionnaire for intermittent claudication (2003)
Presentation / Conference Contribution
Venkatasubramaniam, A., Mylankal, K., McCollum, P., Mehta, T., & Chetter, I. A novel disease-specific quality of life questionnaire for intermittent claudication

Disease-specific quality of life assessment in intermittent claudication: review (2003)
Journal Article
Mehta, T., Subramaniam, A., Chetter, I., & McCollum, P. (2003). Disease-specific quality of life assessment in intermittent claudication: review. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery, 25(3), 202-208. https://doi.org/10.1053/ejvs.2002.1837

Objectives: intermittent claudication (IC) is a common condition that has a major impact on the patients' quality of life (QoL). Generic QoL instruments often lack sensitivity to detect small but clinically significant variation in QoL. Disease-speci... Read More about Disease-specific quality of life assessment in intermittent claudication: review.